Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies

por Rixe, Olivier, Puzanov, Igor, LoRusso, Patricia M., Cohen, Roger B., Morris, John C., Olowokure, Olugbenga O., Yin, Jian Y., Doroumian, Séverine, Shen, Liji, Olszanski, Anthony J.
Publicado 2015

A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function

por Azaro, Analía, Rodón, Jordi, Machiels, Jean-Pascal, Rottey, Sylvie, Damian, Silvia, Baird, Richard, Garcia-Corbacho, Javier, Mathijssen, Ron H. J., Clot, Pierre-François, Wack, Claudine, Shen, Liji, de Jonge, Maja J. A.
Publicado 2016

Olaparib in patients with mCRPC with homologous recombination repair gene alterations: PROfound Asian subset analysis

por Matsubara, Nobuaki, Nishimura, Kazuo, Kawakami, Satoru, Joung, Jae Young, Uemura, Hiroji, Goto, Takayuki, Kwon, Tae Gyun, Sugimoto, Mikio, Kato, Masashi, Wang, Shian-Shiang, Pang, See-Tong, Chen, Chung-Hsin, Fujita, Tomoko, Nii, Masahiro, Shen, Liji, Dujka, Melanie, Hussain, Maha, de Bono, Johann
Publicado 2022

A DREAM Challenge to Build Prediction Models for Short-Term Discontinuation of Docetaxel in Metastatic Castration-Resistant Prostate Cancer

por Seyednasrollah, Fatemeh, Koestler, Devin C., Wang, Tao, Piccolo, Stephen R., Vega, Roberto, Greiner, Russell, Fuchs, Christiane, Gofer, Eyal, Kumar, Luke, Wolfinger, Russell D., Kanigel Winner, Kimberly, Bare, Chris, Neto, Elias Chaibub, Yu, Thomas, Shen, Liji, Abdallah, Kald, Norman, Thea, Stolovitzky, Gustavo, Soule, Howard R., Sweeney, Christopher J., Ryan, Charles J., Scher, Howard I., Sartor, Oliver, Elo, Laura L., Zhou, Fang Liz, Guinney, Justin, Costello, James C.
Publicado 2017